Personalized mRNA cancer vaccine cut melanoma death, recurrence by 42%

Markers released top-line results today after previously reporting trial succeeded.
https://arstechnica.com/health/2026/10/personalized-mrna-cancer-vaccine-cut-melanoma-death-recurrence-by-42/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social